(redirected from androgen deprivation)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to androgen deprivation: Androgen Deprivation Therapy
See: abridgment, absence, attachment, censorship, condemnation, constraint, conversion, curtailment, defeasance, deficiency, detriment, discipline, disqualification, disseisin, distress, escheatment, expense, expropriation, expulsion, foreclosure, forfeiture, injury, loss, misappropriation, omission, ouster, paucity, penalty, pillage, privation, punishment, rejection, restriction, sacrifice, sanction, sequestration, spoliation, taking

DEPRIVATION, ecclesiastical Punishment. A censure by which a clergyman is deprived of his parsonage, vicarage, or other ecclesiastical promotion or dignity. Vide Ayliffe's Parerg. 206; 1 Bl. Com. 393.

References in periodicals archive ?
Radical prostatectomy and/or radiotherapy are the treatment modalities adopted for organ confined prostate cancer however androgen deprivation therapy (ADT) is the essential part of standard treatment for men with advanced prostate cancer3.
The team's hypothesis is that metastatic prostate cancer patients with the weakest response to androgen-deprivation therapy could be given GCP concurrently with androgen deprivation therapy to retain Filamin A in the nucleus, thereby allowing cancer cells to die off.
This is also referred to as complete androgen deprivation (CAD).
Androgen deprivation therapy: reduces levels of androgens in the body, slowing the growth of prostate cancers; achieved through orchiectomy, luteinizing hormone-releasing hormone analogs or antagonists, or antiandrogens
This population-based cohort study examined whether androgen deprivation therapy (orchiectomy or luteinizing hormone-releasing hormone) is associated with improved survival among elderly men with localized prostate cancer, when compared with conservative management (i.
Improvements in bone mineral density in men with prostate cancer on androgen deprivation are greatest in men who continue to receive alendronate therapy," Greenspan's group concludes.
Many men with prostate cancer receive treatment with primary androgen deprivation therapy (PADT) as an alternative to surgery, radiation, or other traditional forms of treatment.
Following therapy for prostate cancer, it is critical that the clinician provide the pertinent history of androgen deprivation or radiation therapy to assist the pathologist in rendering the correct diagnosis.
the Men's Health Biotech Company, has announced the results of a lipid interim analysis of the pivotal Phase III ADT clinical trial evaluating oral, once daily ACAPODENE(R) (toremifene citrate) 80mg for the treatment of the multiple serious side effects of androgen deprivation therapy (ADT) in men with advanced prostate cancer.
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.

Full browser ?